SLC5A2 and Hyperglycemia: Experimentally, there are also emerging data to suggest mechanisms beyond the reduction in body weight and hyperglycemia, and a potential role for the decrease in chronic inflammation and oxidative stress associated with SGLT-2 inhibitor treatment [36].